Rounds were not that big this week, as only a handful were $100 million or more. Much like last week, investment was all over the board, as storage...
Health, Wellness & Biotech
Medical device startup General Prognostics raised $3.25 million in seed funding to launch a wearable monitoring device. It鈥檚 one of several startups...
London-based Pheon Therapeutics made its debut Wednesday armed with $68 million to address a slate of cancers.
The deal, which is expected to close in October, will put Torrent among the top ten largest dermatology firms in India,
Big funding rounds again seemed to slow down in a week that highlighted the diverse interests of investors, as large rounds went to companies in...
The fresh funding will go towards pushing its drug candidate, HU6, through clinical trials.
Cambridge, Massachusetts-based Third Harmonic Bio joined fellow sector IPOs by Seattle-based Know Labs and Texas-based BioAffinity Technologies.
CytoReason and Pfizer are re-upping their three-year partnership with a fresh, ambitious goal. The companies announced they would renew their...
The psychedelic drug startup industry isn't blowing up quite the way industry watchers expected. But startups in the space that aren't drug related...
After four years of optimistic funding fueled by strong research from top-tier universities, the novelty surrounding startups in the psychedelics...
Biomedical platform Galvanize Therapeutics announced on Thursday it raised $100 million in Series B financing led by Fidelity Management and Research...


67.1K Followers